Intervention

LY2216684

ClinicalTrials.gov intervention label

Clinical trials24
Recruiting0
Common conditions3
Lead sponsors shown1

Clinical trials

24 shown
A Study to Evaluate the Effect of Clarithromycin on LY2216684NCT01460407 · 2011-10-01
COMPLETED
A Study to Evaluate the Effect of Genotype on LY2216684NCT01460381 · 2011-10-01
COMPLETED
A Study of LY2216684 in Participants With Major Depression DisorderNCT01370499 · 2011-08-01
COMPLETED
A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy SubjectsNCT01389752 · 2011-07-01
COMPLETED
A Study to Evaluate the Effect of Food on LY2216684NCT01389765 · 2011-07-01
COMPLETED
A Study of LY2216684 in Healthy ParticipantsNCT01380691 · 2011-06-01
COMPLETED
A Study of LY2216684 in Healthy FemalesNCT01373931 · 2011-06-01
COMPLETED
A Study in Prevention of Re-emergence of Depression SymptomsNCT01299272 · 2011-05-01
COMPLETED
A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) TreatmentNCT01187407 · 2011-03-01
COMPLETED
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake InhibitorNCT01185340 · 2011-03-01
COMPLETED
A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake InhibitorsNCT01263223 · 2010-12-01
COMPLETED
A Study of LY2216684 and Digoxin in Healthy SubjectsNCT01266590 · 2010-12-01
COMPLETED
A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of ClopidogrelNCT01263093 · 2010-12-01
COMPLETED
A Study of LY2216684 and Theophylline in Healthy SubjectsNCT01263106 · 2010-12-01
COMPLETED
A Study of LY2216684 and Warfarin in Healthy SubjectsNCT01263119 · 2010-12-01
COMPLETED
A Study of LY2216684 in Healthy Participants Receiving Albuterol or PropanololNCT01263197 · 2010-12-01
COMPLETED
A Study of the Effect of LY2216684 on LorazepamNCT01275144 · 2010-12-01
COMPLETED
A Pharmacokinetic Study of the Coadministration of LY2216684 With SertralineNCT01250873 · 2010-11-01
COMPLETED
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderNCT01173601 · 2010-11-01
COMPLETED
A Study of LY2216684 in Participants With Impaired Hepatic FunctionNCT01241435 · 2010-10-01
COMPLETED
A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.NCT01243957 · 2010-10-01
COMPLETED
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderNCT00840034 · 2009-02-01
COMPLETED
A Study in Adult Patients With Major Depressive DisorderNCT00795821 · 2008-12-01
COMPLETED
A Study for Participants With Major DepressionNCT00420004 · 2006-12-01
COMPLETED

Trial status mix

COMPLETED24

Phase mix

PHASE116
PHASE36
PHASE23

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.